Larvol Delta - Comparison-of-Pharmacokinetic-Similarity-Immunogenicity-and-Safety-of-Ustekinumab-and-BAT2206-in-Healthy-Chinese-Male-Subjects-in-a-DoubleBlind-Randomized-SingleDose-ParallelGroup-Phase-I-Trial

Stelara (ustekinumab) - J&J

BAT2206 (ustekinumab biosimilar) - Bio-Thera Solutions, Pharmapark, Hikma

http://www.ncbi.nlm.nih.gov/pubmed/36417156

Nov 24, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next